Artificial intelligence-powered analysis of medical images for early detection of neurodegenerative diseases

Samuel Fanijo 1, *, Uyok Hanson 2, Taiwo Akindahunsi 3, Idris Abijo 4 and Tinuade Bolutife Dawotola 5

1 Department of Computer Science, Iowa State University, USA.
2 Department of Educational Psychology, Texas A&M University, Texas, USA.
3 Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
4 Department of Physics and Astronomy, University of Tennessee, Knoxville, USA.
5 Department of Mathematics and Philosophy, Western Illinois University, Illinois, USA.
 
Review Article
World Journal of Advanced Research and Reviews, 2023, 19(02), 1578–1587
Article DOI10.30574/wjarr.2023.19.2.1432
 
Publication history: 
Received on 07 June 2023; revised on 20 August 2023; accepted on 23 August 2023
 
Abstract: 
Neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's offer serious health issues to people all over the world, due to their progressive nature and lack of effective therapies. In order to improve patient outcomes and allow for prompt action to limit the progression of the disease, early identification is essential. With a focus on deep learning methods, this study investigates the use of AI-powered analysis of medical images for the early detection of neurodegenerative disorders. The use of several medical imaging modalities, such as PET, CT, and MRI, in identifying disease biomarkers at an early stage is investigated. The usefulness of deep learning techniques to automate feature extraction, categorize illness states, and track disease progression is highlighted. These techniques include convolutional neural networks [CNNs], recurrent neural networks [RNNs], and generative adversarial networks [GANs]. The study also discusses the difficulties in using AI implementation, including data quality, image variability, and the interpretability of AI models. Furthermore, the study explores possible regulatory and ethical considerations in clinical adoption. It also examines AI's growing role in clinical settings and its ability to work with personalized medicine which present promising opportunities for improving the diagnosis and management neurodegenerative disease. The final section of this paper outlines important future directions for increasing the use of AI in clinical care, including multi-modal fusion and transfer learning.
 
Keywords: 
Artificial Intelligence; Deep Learning; Neurodegenerative Diseases; Medical Imaging; Early Detection.
 
Full text article in PDF: 
Share this